Researchers spearhead groundbreaking research into treatment of brain swelling

May 22, 2012

Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury to the brain, out of hospital cardiac arrest or stroke. The research, which is published this week in the international journal, Nature Communications, uses a radically new patented technology, developed in Ireland and termed, 'Neuronal Barrier Modulation' which has been shown in an animal model simulating human brain swelling, to be highly effective in reducing the dangerous effects of this condition, while improving cognitive outcome. The research was sponsored by the US Department of Defense and Enterprise Ireland.

The researchers have devised a method of safely manipulating the blood vessels in the brain to allow for periodic opening of tight junction channels between cells lining the vessels. A simple medication can be injected into a peripheral vein, rendering the blood vessels in the brain marginally and reversibly permeable to and this procedure allows the fluid in the brain, largely comprising water, to efficiently drain back into the blood.

"Unfortunately, there has been little change in treatment of acute over the past 80 years and this is a major cause of mortality in traumatic brain injury (TBI), stroke and out-of-hospital cardiac arrest," says Senior Author of the Nature Communications paper, Dr. Matthew Campbell, of the Ocular Genetics Unit at Trinity College Dublin. "We developed the technique initially for treatment of neuronal edema in cases where injury has occurred to the , the region of the brain involved in vision, in view of our Unit's profile in vision research, however, the same method can be used in alleviating edema in all ," says Dr. Campbell.

In Europe alone, brain injuries cause over 66,000 deaths while almost 1.6 million people are admitted to hospital each year. Similar numbers are affected by stroke and cardiac arrest. In fact, more people suffer a (TBI) each year than the numbers diagnosed with breast, lung, prostate, brain, and colon cancer combined.

"The medication is based on the use of RNA Interference, a demanding technology which has had a bumpy ride within the pharmaceuticals industry in recent years, and I am delighted that a highly effective and simply deployable therapeutic strategy has emerged based on this technology. There is now a clear path to clinical deployment," says Professor Pete Humphries, Director of the Ocular Genetics Unit at Trinity College Dublin, where the work was carried out.

"Malignant brain swelling as a consequence of , head injury, stroke, and brain tumours is the single most common factor leading to death in Western society and plays a major role in worsening the outcome of those who survive. Given how common these conditions are, anything that could significantly reduce the effect of swelling is likely to have a profound impact on morbidity and mortality and will have reverberations though the public health system," continued co-author, neurologist, Dr Colin Doherty, MD, St James's Hospital, Dublin.

The technology the researchers have reported is planned to enter Phase I clinical trials both here, with neurologist Dr Colin Doherty and in the US along with the team's collaborator, neurosurgeon Professor Gerald Grant, at Duke University and will be developed by the recently established Irish Company, Avena Therapeutics Ltd. Veteran life-science investor and Executive Chairman of the Company, Jeremy L. Curnock Cook says: "This sort of thing doesn't happen too often and we have now been presented with a remarkable and exciting opportunity thanks to the Trinity researchers and their supporters both here and in the US".

Explore further: Traumatic brain injury: NIH-funded researchers will assess biomarkers for diagnosis and treatment

More information: Full title of the paper "Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury"

Related Stories

Traumatic brain injury: NIH-funded researchers will assess biomarkers for diagnosis and treatment

August 3, 2011
Biomarkers in the bloodstream could provide physicians with a quick and accurate method of assessing the severity of traumatic brain injury (TBI) and helping deliver and monitor the results of therapies, such as progesterone ...

Traumatic brain injury linked with tenfold increase in stroke risk

July 28, 2011
If you suffer traumatic brain injury, your risk of having a stroke within three months may increase tenfold, according to a new study reported in Stroke: Journal of the American Heart Association.

Skull resconstruction immediately following traumatic brain injury worsens brain damage

March 22, 2012
Immediate skull reconstruction following trauma that penetrates or creates an indentation in the skull can aggravate brain damage inflicted by the initial injury, a study by a University of South Florida research team reports. ...

Recommended for you

Image ordering often based on factors other than patient need: study

September 25, 2017
Do you really need that MRI?

Bone marrow concentrate improves joint transplants

September 25, 2017
Biologic joint restoration using donor tissue instead of traditional metal and plastic may be an option for active patients with joint defects. Although recovery from a biologic joint repair is typically longer than traditional ...

How ketogenic diets curb inflammation

September 25, 2017
Ketogenic diets – extreme low-carbohydrate, high-fat regimens that have long been known to benefit epilepsy and other neurological illnesses – may work by lowering inflammation in the brain, according to new research ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.